These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 29864158

  • 1. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC, Liao CK, Tsai YH, Tseng TJ, Chuang LC, Lan CT, Chang HM, Liu CH.
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [Abstract] [Full Text] [Related]

  • 2. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K, Linskey ME, Bota DA.
    Oncogene; 2013 Oct 17; 32(42):5038-47. PubMed ID: 23178488
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis.
    Liao WC, Yen HR, Liao CK, Tseng TJ, Lan CT, Liu CH.
    Am J Cancer Res; 2019 Oct 17; 9(2):347-362. PubMed ID: 30906633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M, Mukasa A, Inda MM, Zhang J, Chin L, Cavenee W, Furnari F.
    J Exp Med; 2011 Dec 19; 208(13):2657-73. PubMed ID: 22162832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of transcriptional coactivator TAZ in gliomas.
    Li W, Dong S, Wei W, Wang G, Zhang A, Pu P, Jia Z.
    Oncotarget; 2016 Dec 13; 7(50):82686-82699. PubMed ID: 27764783
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers.
    Xu H, Liu P, Yan Y, Fang K, Liang D, Hou X, Zhang X, Wu S, Ma J, Wang R, Li T, Piao H, Meng S.
    J Exp Clin Cancer Res; 2020 Feb 28; 39(1):44. PubMed ID: 32111229
    [Abstract] [Full Text] [Related]

  • 20. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
    Syx D, Van Damme T, Symoens S, Maiburg MC, van de Laar I, Morton J, Suri M, Del Campo M, Hausser I, Hermanns-Lê T, De Paepe A, Malfait F.
    Hum Mutat; 2015 May 28; 36(5):535-47. PubMed ID: 25703627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.